Discover why traditional ideas of “relapsing” and “stable” MS may miss the silent damage happening beneath the surface. Prof Giovannoni will break down the latest research, explain what smouldering MS means for long-term outcomes, and discuss practical implications for treatment decisions today.
You’ll learn how to better recognise “smouldering” disease activity, what to ask your healthcare team, and how early, effective treatment may change your MS journey.
Date: December 9th
Time: 7pm
Registration required – Register for the webinar
Prof Gavin Giovannoni MS Webinar Speaker Bio
Professor Gavin Giovannoni MBBCh, PhD, FCP (S.A., Neurol.), FRCP, FRCPath. Gavin Giovannoni is Professor of Neurology at the Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London. His clinical interests are multiple sclerosis (MS) and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease-modifying therapies. His current research is focused on the Epstein-Barr virus as the cause of MS, strategies to prevent MS, MS-related neurodegeneration and MS therapies. His team focus on translational research and has an active clinical trial programme.
This webinar is kindly supported by Sanofi, who have had no input on the content.